Breaking News, Promotions & Moves

Cytovance Promotes Jesse McCool to CEO

Yan Wang to step down as Cytovance’s interim chief executive

By: Contract Pharma

Contract Pharma Staff

Cytovance Biologics, a biopharmaceutical contract development and manufacturing organization (CDMO), has appointed Dr. Jesse McCool to chief executive officer. Dr. Yan Wang will step down as Cytovance’s interim chief executive while continuing to serve as director of the board for Cytovance and chief executive officer of SPL. Dr. McCool will report to Frank Sun, executive director and vice chairman of the board for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. and chairman of the board for Cy...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters